https://nefro-nl.nl/study/sack-apixaban-bij-nierziekte-stadium-5-en-atriumfibrilleren/ 2026-11-11T16:08:26+00:00 https://nefro-nl.nl/study/podomount-basket-onderzoek-naar-bi-764198-bij-nierziekten/ 2026-11-11T16:08:37+00:00 https://nefro-nl.nl/study/podomount-pfsgs-onderzoek-naar-bi-764198-bij-fsgs/ 2026-11-11T16:08:46+00:00 https://nefro-nl.nl/study/promise-chronische-nierschade/ 2026-11-11T16:08:53+00:00 https://nefro-nl.nl/study/baxduo-pacific-chronische-nierschade/ 2026-11-11T16:09:02+00:00 https://nefro-nl.nl/study/mezagitamab-bij-primaire-iga-nefropathie/ 2026-11-11T16:09:10+00:00 https://nefro-nl.nl/en/study/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation/ 2026-11-11T16:09:23+00:00 https://nefro-nl.nl/en/study/podomount-basket-bi-764198-in-proteinuric-kidney-diseases/ 2026-11-11T16:09:30+00:00 https://nefro-nl.nl/en/study/podomount-pfsgs-bi-764198-in-focal-segmental-glomerulosclerosis/ 2026-11-11T16:09:37+00:00 https://nefro-nl.nl/en/study/potassium-correction-for-raas-optimization-in-chronic-kidney-disease-promise/ 2026-11-11T16:09:51+00:00 https://nefro-nl.nl/en/study/baxduo-pacific-baxdrostat-and-dapagliflozin-in-chronic-kidney-disease/ 2026-11-11T16:10:01+00:00 https://nefro-nl.nl/en/study/mezagitamab-for-primary-iga-nephropathy/ 2026-11-11T16:10:08+00:00